Caw-it, Reycel P.

HRN: 21-53-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2022
CEFUROXIME 750MG (VIAL)
07/12/2022
07/19/2022
IVT
750mg
Q8
Fracture Close Complete Displaced D3rd Femur R
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: